Skip to main content
. 2019 Mar 5;316(6):E1118–E1135. doi: 10.1152/ajpendo.00496.2018

Fig. 5.

Fig. 5.

A: total triglyceride content of livers from 5-h-fasted, 6-wk-old integrin-linked kinase (ILK)lox/lox (n = 7) and hepILK-knockout (KO) (n = 8) mice. B: quantification of triglyceride side chain species from A. C: total diglyceride content of livers from 5-h-fasted, 6-wk-old ILKlox/lox (n = 7) and hepILK-KO (n = 8) mice. D: quantification of diglyceride side chain species from D. E: total cholesterol content of livers from 5-h-fasted, 6-wk-old ILKlox/lox (n = 7) and hepILK-KO (n = 8) mice. F: concentration of nonesterified fatty acids (NEFA) in plasma samples taken at t = 100 during metabolic flux analysis (MFA) studies of 6-wk-old ILKlox/lox (n = 8) and hepILK-KO (n = 7) mice. G: concentration of higher level plasma amino acids and related metabolites in plasma samples taken at t = 120 during MFA studies of 6-wk-old ILKlox/lox (n = 8) and hepILK-KO (n = 7) mice. H: concentration of lower level plasma amino acids and related metabolites in plasma samples taken at t = 120 during MFA studies of 6-wk-old ILKlox/lox (n = 8) and hepILK-KO (n = 7) mice. All amino acids are depicted with standard 3-letter abbreviations. The remaining metabolites are as follows: γ-AA, γ-aminobutyric acid; Citru, citrulline; 1-mHis, 1-methyl-histidine; Orn, ornithine; PE, phosphoethanolamine; Taur, taurine. Data are means ± SE. *P < 0.05. ND, not detectable; NS, not significant.